U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036419) titled 'A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients' on June 16.
Brief Summary: The study is being conducted to evaluate the efficacy and safety of Remimazolam for intraoperative sedation in pediatric and adolescent patients.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Operative Sedation of Pediatric
Operative Sedation of Adolescent Patients
Intervention:
DRUG: Remimazolam Tosilate for injection
Remimazolam Tosilate for injection.
DRUG: Propofol Injection
Propofol injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Discla...